本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Collegium Pharmaceutical, Inc.

26.79
+0.01000.04%
盤後26.790.00000.00%16:20 EDT
成交量:21.44萬
成交額:571.66萬
市值:8.61億
市盈率:14.43
高:27.09
開:26.60
低:26.22
收:26.78
資料載入中...
2024/02/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/22

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/22

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/03

重要事件披露

Form 8-K - Current report
2023/12/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/09

重要事件披露

Form 8-K - Current report
2023/11/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/08

重要事件披露

Form 8-K - Current report
2023/08/24

重要事件披露

Form 8-K - Current report
2023/08/10

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/08/07

重要事件披露

Form 8-K - Current report
2023/08/03

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]